Article Text

Download PDFPDF

Original research
Loss of hepatic Mboat7 leads to liver fibrosis
  1. Veera Raghavan Thangapandi1,2,
  2. Oskar Knittelfelder3,
  3. Mario Brosch1,2,
  4. Eleonora Patsenker4,
  5. Olga Vvedenskaya3,
  6. Stephan Buch1,2,
  7. Sebastian Hinz5,
  8. Alexander Hendricks5,
  9. Marina Nati6,
  10. Alexander Herrmann1,2,
  11. Devavrat Ravindra Rekhade1,2,
  12. Thomas Berg7,
  13. Madlen Matz-Soja7,8,
  14. Klaus Huse9,
  15. Edda Klipp10,
  16. Josch K Pauling10,11,
  17. Judith AH Wodke10,
  18. Jacobo Miranda Ackerman3,
  19. Malte von Bonin1,12,
  20. Elmar Aigner13,
  21. Christian Datz14,
  22. Witigo von Schönfels5,
  23. Sophie Nehring1,2,
  24. Sebastian Zeissig1,2,
  25. Christoph Röcken15,
  26. Andreas Dahl2,
  27. Triantafyllos Chavakis3,6,16,17,
  28. Felix Stickel4,
  29. Andrej Shevchenko3,
  30. Clemens Schafmayer18,
  31. Jochen Hampe1,2,
  32. Pallavi Subramanian6
  1. 1Department of Medicine I, University Hospital Dresden, Technische Universität (TU) Dresden, Dresden, Sachsen, Germany
  2. 2Center for Regenerative Therapies Dresden (CRTD), Technische Universität (TU) Dresden, Dresden, Germany
  3. 3Max-Planck-Institute of Molecular Cell Biology and Genetics, Dresden, Sachsen, Germany
  4. 4Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland
  5. 5Department of Visceral and Thoracic Surgery, Universitatsklinikum Schleswig-Holstein, Kiel, Schleswig-Holstein, Germany
  6. 6Institute for Clinical Chemistry and Laboratory Medicine, University Hospital Dresden, Technische Universität (TU) Dresden, Dresden, Sachsen, Germany
  7. 7Division of Hepatology, Department of Oncology, Gastroenterology, Hepatology Pulmonology, and Infectious Diseases, University Hospital Leipzig, Leipzig, Sachsen, Germany
  8. 8Rudolf Schönheimer- Institute of Biochemistry, University of Leipzig Faculty of Medicine, Leipzig, Germany
  9. 9Leibniz Institute for Age Research Fritz-Lipmann Institute, Jena, Thüringen, Germany
  10. 10Department of Theoretical Biophysics, Institute of Biology, Humboldt-Universität zu Berlin, Berlin, Germany
  11. 11LipiTUM, Chair of Experimental Bioinformatics, TUM School of Life Sciences, Technical University of Munich, Freising, Bayern, Germany
  12. 12German Cancer Consortium, Heidelberg, Baden-Württemberg, Germany
  13. 13Department of Medicine, Paracelsus Medical University Salzburg, Salzburg, Austria
  14. 14Department of Internal Medicine, Hospital Oberndorf, Teaching Hospital of the Paracelsus Private University of Salzburg, Obendorf, Austria
  15. 15Department of Pathology, University Hospital Schleswig Holstein, Kiel, Schleswig-Holstein, Germany
  16. 16German Center for Diabetes Research, Neuherberg, Germany
  17. 17Paul Langerhans Institute Dresden, Helmholtz Zentrum München, University Hospital Dresden, Technische Universität (TU) Dresden, Dresden, Sachsen, Germany
  18. 18Department of General, Visceral, Vascular and Transplantation Surgery, University of Rostock, Rostock, Mecklenburg-Vorpommern, Germany
  1. Correspondence to Professor Jochen Hampe, Department of Gastroenterology, and Hepatology MK1, University Hospital Dresden, Dresden 01307, Sachsen, Germany; jochen.hampe{at}uniklinikum-dresden.de

Abstract

Objective The rs641738C>T variant located near the membrane-bound O-acyltransferase domain containing 7 (MBOAT7) locus is associated with fibrosis in liver diseases, including non-alcoholic fatty liver disease (NAFLD), alcohol-related liver disease, hepatitis B and C. We aim to understand the mechanism by which the rs641738C>T variant contributes to pathogenesis of NAFLD.

Design Mice with hepatocyte-specific deletion of MBOAT7 (Mboat7Δhep) were generated and livers were characterised by histology, flow cytometry, qPCR, RNA sequencing and lipidomics. We analysed the association of rs641738C>T genotype with liver inflammation and fibrosis in 846 NAFLD patients and obtained genotype-specific liver lipidomes from 280 human biopsies.

Results Allelic imbalance analysis of heterozygous human liver samples pointed to lower expression of the MBOAT7 transcript on the rs641738C>T haplotype. Mboat7Δhep mice showed spontaneous steatosis characterised by increased hepatic cholesterol ester content after 10 weeks. After 6 weeks on a high fat, methionine-low, choline-deficient diet, mice developed increased hepatic fibrosis as measured by picrosirius staining (p<0.05), hydroxyproline content (p<0.05) and transcriptomics, while the inflammatory cell populations and inflammatory mediators were minimally affected. In a human biopsied NAFLD cohort, MBOAT7 rs641738C>T was associated with fibrosis (p=0.004) independent of the presence of histological inflammation. Liver lipidomes of Mboat7Δhep mice and human rs641738TT carriers with fibrosis showed increased total lysophosphatidylinositol levels. The altered lysophosphatidylinositol and phosphatidylinositol subspecies in MBOAT7Δhep livers and human rs641738TT carriers were similar.

Conclusion Mboat7 deficiency in mice and human points to an inflammation-independent pathway of liver fibrosis that may be mediated by lipid signalling and a potentially targetable treatment option in NAFLD.

  • NAFLD
  • NASH
  • liver fibrosis, lipidomics
http://creativecommons.org/licenses/by-nc/4.0/

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

View Full Text

Statistics from Altmetric.com

Footnotes

  • JH and PS are joint senior authors.

  • Contributors Project was conceived and experiments were conceptualised by: VRT, PS, MB, EK, TC, FS, MMS, and JH. Experiments were performed by VRT, PS, OK, EP, OV, KH, MN, SN, AD, DRR and MVB. Patient sample collection and coordination was done by CS, WVS, SH, AH, TB, EA, CD and CR. Data analysis was done by VRT, PS, SB, AH, JAHW, JKP and JMA. Manuscript was written and edited by VRT, PS, JH, TC, AS, SZ and FS.

  • Funding This study was supported by the German Ministry of Research and Education (BmBF) through the Liver Systems Medicine (LiSyM) network grant (to JH and AS) and ERACOSysMed (Dynaflow) grant (to JH), an ERC grant (DEMETINL to TC) and Lipidomics and Informatics for Life Sciences (LIFS) grant Unit of the de. NBI Consortium (AS). Additional support came from the Swiss National Funds (grants 310030_138747/1 and 310030_169196 to F.S.) Contributions by JP were partly funded by the Bavarian State Ministry of Science and the Arts in the framework of the Centre Digitisation. Bavaria (ZDB).

  • Competing interests None declared.

  • Patient and public involvement Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.

  • Patient consent for publication Not required.

  • Ethics approval Subjects recruited for the genetic association study came from different sites, at which the study protocol was approved by the ethics committees of the participating institutions.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data availability statement Data are available on reasonable request. Not applicable.

  • Author note The transciptomic data is available at GEO under id GSE139992

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.